Treatment of GVHD in Hematopoietic Stem Cell Transplant (HSCT) Recipients Using AAT Plus Corticosteroids (CS) Compared With Corticosteroids Alone

NCT04167514 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

136

Enrollment

INDUSTRY

Sponsor class

Conditions

Graft Versus Host Disease (GVHD)

Interventions

BIOLOGICAL: Alpha-1 antitrypsin (AAT)
DRUG: Placebo

Sponsor

CSL Behring

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]